| Display title | Chemistry:Desloratadine |
| Default sort key | Desloratadine |
| Page length (in bytes) | 13,392 |
| Namespace ID | 3022 |
| Namespace | Chemistry |
| Page ID | 803720 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
| Counted as a content page | Yes |
| Page image |  |
| HandWiki item ID | None |
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
| Page creator | imported>Carolyn |
| Date of page creation | 09:34, 8 February 2024 |
| Latest editor | imported>Carolyn |
| Date of latest edit | 09:34, 8 February 2024 |
| Total number of edits | 1 |
| Recent number of edits (within past 90 days) | 0 |
| Recent number of distinct authors | 0 |
Description | Content |
Article description: (description)
This attribute controls the content of the description and og:description elements. | Desloratadine (trade names Clarinex and Aerius) is a tricyclic H1 inverse agonist that is used to treat allergies. It is an active metabolite of loratadine.
It was patented in 1984 and came into medical use in 2001. |
